Repligen
RGEN
#2045
Rank
โ‚ฌ7.97 B
Marketcap
141,70ย โ‚ฌ
Share price
-0.47%
Change (1 day)
0.34%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): โ‚ฌ19.53 Million

According to Repligen 's latest financial reports the company's current earnings are โ‚ฌ0.70 Billion. In 2024 the company made an earning of -โ‚ฌ5.42 Million a decrease over its 2023 earnings that were of โ‚ฌ41.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ19.53 M-460.73%
2024 -โ‚ฌ5.42 Million-113.01%
2023 โ‚ฌ41.61 M-78.01%
2022 โ‚ฌ0.18 B33.37%
2021 โ‚ฌ0.14 B131.52%
2020 โ‚ฌ61.28 M101.31%
2019 โ‚ฌ30.44 M25.93%
2018 โ‚ฌ24.17 M105.61%
2017 โ‚ฌ11.75 M-11.46%
2016 โ‚ฌ13.27 M14.91%
2015 โ‚ฌ11.55 M20.26%
2014 โ‚ฌ9.6 M-51.49%
2013 โ‚ฌ19.8 M90.98%
2012 โ‚ฌ10.37 M
2010 โ‚ฌ0.15 M-103.81%
2009 -โ‚ฌ3.94 Million-223.84%
2008 โ‚ฌ3.18 M
2006 -โ‚ฌ2.14 Million229.64%
2005 -โ‚ฌ0.65 Million-89.16%
2004 -โ‚ฌ5.99 Million-16.86%
2003 -โ‚ฌ7.2 Million88.72%
2002 -โ‚ฌ3.82 Million-27.88%
2001 -โ‚ฌ5.29 Million-1.74%
2000 -โ‚ฌ5.39 Million85.93%
1999 -โ‚ฌ2.9 Million159.16%
1998 -โ‚ฌ1.12 Million85.71%
1997 -โ‚ฌ0.61 Million-70.83%
1996 -โ‚ฌ2.07 Million-72.41%
1995 -โ‚ฌ7.48 Million-60.63%
1994 -โ‚ฌ18.99 Million45.39%
1993 -โ‚ฌ13.06 Million39.45%
1992 -โ‚ฌ9.37 Million-32.3%
1991 -โ‚ฌ13.83 Million6.62%
1990 -โ‚ฌ12.97 Million1577.78%
1989 -โ‚ฌ0.78 Million-57.14%
1988 -โ‚ฌ1.81 Million-362.5%
1987 โ‚ฌ0.68 M-130.77%
1986 -โ‚ฌ2.24 Million136.36%
1985 -โ‚ฌ0.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
โ‚ฌ0.32 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.58 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.50 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ8.81 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ6.09 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ99.24 M 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ93.65 Million-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚ฌ19.07 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA